呼吸指南

订阅

MedSci主页 / 所有栏目 / 呼吸指南

2019 AASM临床实践指南：应用气道正压治疗成人阻塞性睡眠呼吸暂停

2019-02-15 美国睡眠医学会 J Clin Sleep Med. 2019;15(2):335–343.

气道正压治疗阻塞性睡眠呼吸暂停

2019年2月，美国睡眠医学会(AASM)发布了成人阻塞性睡眠呼吸暂停气道正压治疗指南，文章主要内容涉及气道正压治疗成人阻塞性睡眠呼吸暂停的适应证，并针对3个PICO问题提出9条推荐意见。

中文标题：

2019 AASM临床实践指南：应用气道正压治疗成人阻塞性睡眠呼吸暂停

英文标题：

Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline

发布机构：

美国睡眠医学会

发布日期：

2019-02-15

简要介绍：

2019年2月，美国睡眠医学会(AASM)发布了成人阻塞性睡眠呼吸暂停气道正压治疗指南，文章主要内容涉及气道正压治疗成人阻塞性睡眠呼吸暂停的适应证，并针对3个PICO问题提出9条推荐意见。 

拓展指南：与阻塞性睡眠呼吸暂停相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2019 AASM临床实践指南：应用气道正压治疗成人阻塞性睡眠呼吸暂停)] GetToolGuiderByIdResponse(projectId=1, id=29c8a1c001e06603, title=2019 AASM临床实践指南：应用气道正压治疗成人阻塞性睡眠呼吸暂停, enTitle=Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline, guiderFrom=J Clin Sleep Med. 2019;15(2):335–343., authorId=null, author=, summary=2019年2月，美国睡眠医学会(AASM)发布了成人阻塞性睡眠呼吸暂停气道正压治疗指南，文章主要内容涉及气道正压治疗成人阻塞性睡眠呼吸暂停的适应证，并针对3个PICO问题提出9条推荐意见。 , cover=, journalId=null, articlesId=null, associationId=38, associationName=美国睡眠医学会, associationIntro=美国睡眠医学会（AASM）学院设置睡眠医学保健，教育和出版实践参数，系统评价，临床指南及最佳实践指南的研究等领域的临床标准。每个指南是由独立的专家审查，所有文件至少每5年进行审查一次，并在必要时更新。, copyright=0, guiderPublishedTime=Fri Feb 15 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>2019年2月，美国睡眠医学会(AASM)发布了成人阻塞性睡眠呼吸暂停气道正压治疗指南，文章主要内容涉及气道正压治疗成人阻塞性睡眠呼吸暂停的适应证，并针对3个PICO问题提出9条推荐意见。 </div> <div><br> </div> 拓展指南：<strong>与<font color=red>阻塞性睡眠呼吸暂停</font>相关指南：</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=65dfe1c0016530c9" title="妊娠期阻塞性睡眠呼吸暂停低通气综合征临床诊治专家共识（草案）" target=_blank>妊娠期阻塞性睡眠呼吸暂停低通气综合征临床诊治专家共识（草案）</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=70ff21c0016a1edb" title="2018 ATS临床实践指南：体重管理在治疗成人阻塞性睡眠呼吸暂停中的作用" target=_blank>2018 ATS临床实践指南：体重管理在治疗成人阻塞性睡眠呼吸暂停中的作用</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=cf4b61c001609233" title="2018 SASM指南：成人阻塞性睡眠呼吸暂停患者的术中管理" target=_blank>2018 SASM指南：成人阻塞性睡眠呼吸暂停患者的术中管理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=21bbe1c0016090ad" title="成人阻塞性睡眠呼吸暂停多学科诊疗指南" target=_blank>成人阻塞性睡眠呼吸暂停多学科诊疗指南</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=db1221c00158203c" title="2018 AASM立场声明：医用大麻和阻塞性睡眠呼吸暂停的治疗" target=_blank>2018 AASM立场声明：医用大麻和阻塞性睡眠呼吸暂停的治疗</a></li> 更多信息请点击：<a href="https://www.medsci.cn/guideline/list.do?q=%E9%98%BB%E5%A1%9E%E6%80%A7%E7%9D%A1%E7%9C%A0%E5%91%BC%E5%90%B8%E6%9A%82%E5%81%9C" target=_blank>有关阻塞性睡眠呼吸暂停更多指南</a></ul>, tagList=[TagDto(tagId=87000, tagName=气道正压治疗), TagDto(tagId=3180, tagName=阻塞性睡眠呼吸暂停)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7479, appHits=313, showAppHits=6, pcHits=5145, showPcHits=2919, likes=183, shares=8, comments=4, approvalStatus=1, publishedTime=Sun Feb 24 18:46:44 CST 2019, publishedTimeString=2019-02-15, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Feb 24 18:46:44 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 20:33:49 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 AASM临床实践指南：应用气道正压治疗成人阻塞性睡眠呼吸暂停)])
2019 AASM临床实践指南：应用气道正压治疗成人阻塞性睡眠呼吸暂停
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1206575, encodeId=22d812065e5a7, content=很棒！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59695559216, createdName=Sprite噗, createdTime=Mon Mar 28 10:28:09 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001121, encodeId=80bf1001121a5, content=刚刚好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4b52069935, createdName=fzchenling, createdTime=Tue Jul 20 12:34:52 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885271, encodeId=cfef8852e121, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200831/fb689c3e816d4a64820d63f72073eef4/29c665e5fc1341a9ae58ecf5b979aef9.jpg, createdBy=7e215414767, createdName=ANNA1, createdTime=Mon Sep 14 21:33:36 CST 2020, time=2020-09-14, status=1, ipAttribution=)]
    2022-03-28 Sprite噗

    很棒！！

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1206575, encodeId=22d812065e5a7, content=很棒！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59695559216, createdName=Sprite噗, createdTime=Mon Mar 28 10:28:09 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001121, encodeId=80bf1001121a5, content=刚刚好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4b52069935, createdName=fzchenling, createdTime=Tue Jul 20 12:34:52 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885271, encodeId=cfef8852e121, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200831/fb689c3e816d4a64820d63f72073eef4/29c665e5fc1341a9ae58ecf5b979aef9.jpg, createdBy=7e215414767, createdName=ANNA1, createdTime=Mon Sep 14 21:33:36 CST 2020, time=2020-09-14, status=1, ipAttribution=)]
    2021-07-20 fzchenling

    刚刚好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1206575, encodeId=22d812065e5a7, content=很棒！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59695559216, createdName=Sprite噗, createdTime=Mon Mar 28 10:28:09 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001121, encodeId=80bf1001121a5, content=刚刚好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4b52069935, createdName=fzchenling, createdTime=Tue Jul 20 12:34:52 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885271, encodeId=cfef8852e121, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200831/fb689c3e816d4a64820d63f72073eef4/29c665e5fc1341a9ae58ecf5b979aef9.jpg, createdBy=7e215414767, createdName=ANNA1, createdTime=Mon Sep 14 21:33:36 CST 2020, time=2020-09-14, status=1, ipAttribution=)]
    2020-09-14 ANNA1

    很有用

    1

    展开1条回复